Abbott Laboratories (ABT) | Stock Overview & Key Data
Abbott Laboratories Performance Comparison
Stock Range
Today's Range
Low: $130.54
High: $133.39
on October 2, 2025
52 Week Range
Low: $110.86
High: $141.23
on January 15, 2025
on March 4, 2025
All-Time High: $142.60 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$233.1B
EPS
7.95
P/E Ratio (TTM)
16.74
Forward P/E
25.80
P/B Ratio
4.58
PEG Ratio
0.46
Div. Yield
1.28%
ROE
30.93%
Beta
0.688
Debt to Equity
26.50
Financial Highlights
Profitability
Gross Margin
56.44%
Operating Margin
19.73%
Profit Margin
32.43%
Returns and Earnings
Return on Assets (TTM)
6.62%
Return on Equity (TTM)
30.93%
EBITDA
$11.5B
Net Income (TTM)
$13.9B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$24.89
Quarterly Revenue Growth (YoY)
7.40%
Quarterly Earnings Growth (YoY)
36.60%
Dividend Information
Last 12-Month Dividend
$1.69
Current Dividend Yield
1.28%
3-Year Average Dividend Yield
0.49%
3-Year Average Annual Dividend
$1.92
3-Year Total Dividends
$5.77
Ex-Dividend Date
January 15, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | 233.07B Mega-cap | -0.24% | 1.16% | -0.84% | 0.80% | 17.23% | 18.07% | 30.65% | 21.29% |
| Boston Scientific BSX | 142.83B Large-cap | -1.96% | -9.79% | -7.15% | -3.83% | 7.65% | 13.82% | 142.00% | 133.88% |
| Stryker SYK | 139.22B Large-cap | -0.59% | -6.04% | -6.49% | -2.93% | 2.14% | 4.32% | 75.71% | 64.36% |
| Medtronic plc MDT | 121.93B Large-cap | 1.25% | 2.30% | 8.16% | 7.45% | 19.02% | 8.18% | 15.85% | -12.15% |
| Edwards Lifesciences EW | 45.70B Large-cap | 1.83% | -6.26% | -0.48% | 6.38% | 5.59% | 17.04% | -9.00% | -8.64% |
| Dexcom DXCM | 26.16B Large-cap | -2.72% | -10.58% | -20.51% | -2.49% | -15.36% | -2.45% | -34.95% | -31.15% |
Ownership & Short Interest
Insider Ownership
0.54%
Institutional Ownership
80.77%
Shares Short
18M
Short Ratio
3.68
Short % of Shares Outstanding
1.04%
Average 10-Day Volume
6M
Average 90-Day Volume
5M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is ABT's 52-week high and low?
- In the last 52 weeks, Abbott Laboratories reached a high of $141.23 (on March 4, 2025) and a low of $110.86 (on January 15, 2025).
- What is the market cap and P/E ratio for ABT?
- Curious about Abbott Laboratories's size and valuation? Its market capitalization stands at 233.07B. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.74, and the forward P/E (looking ahead) is 25.80.
- Does ABT pay dividends? If so, what's the yield?
- Yes, Abbott Laboratories is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.28%, and the company has paid an average of $1.92 per share annually over the past 3 years.
- Who are Abbott Laboratories's main competitors or similar companies to consider before investing?
When looking at Abbott Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Boston Scientific
BSX142.83B Healthcare Medical Devices 13.82% 142.00% Stryker
SYK139.22B Healthcare Medical Devices 4.32% 75.71% Medtronic plc
MDT121.93B Healthcare Medical Devices 8.18% 15.85% Edwards Lifesciences
EW45.70B Healthcare Medical Devices 17.04% -9.00% Dexcom
DXCM26.16B Healthcare Medical Devices -2.45% -34.95% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Abbott Laboratories? (e.g., ROE, Debt/Equity)
- To get a sense of Abbott Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 30.93%, the Debt to Equity ratio from the most recent quarter is 26.50, and its Gross Profit Margin stands at 56.44%.
- What is the recent revenue and earnings growth for ABT?
- Looking at Abbott Laboratories's growth, its revenue over the trailing twelve months (TTM) was $43B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.40%, and quarterly earnings saw a YoY growth of 36.60%.
- How much of ABT stock is held by insiders and institutions?
- Wondering who owns Abbott Laboratories stock? Company insiders (like executives and directors) hold about 0.54% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 80.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.